Medicine. Treating neurodegenerative diseases with antibiotics.
Miller
Timothy M
TM
Ludwig Institute for Cancer Research and the Department of Medicine and Neurosciences, University of California, San Diego, La Jolla, CA 92093, USA.
Cleveland
Don W
DW
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001921:Brain / Q000378:metabolism; D002443:Ceftriaxone / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004353:Drug Evaluation, Preclinical; D027342:Excitatory Amino Acid Transporter 2 / Q000235:genetics / Q000378:metabolism; D018698:Glutamic Acid / Q000378:metabolism; D006801:Humans; D051379:Mice; D009046:Motor Neurons / Q000502:physiology; D019636:Neurodegenerative Diseases / Q000188:drug therapy*; D013116:Spinal Cord / Q000378:metabolism; D013569:Synapses / Q000502:physiology; D009435:Synaptic Transmission; D047090:beta-Lactams / Q000494:pharmacology / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D027342:Excitatory Amino Acid Transporter 2; D047090:beta-Lactams; D018698:Glutamic Acid; D002443:Ceftriaxone